Literature DB >> 24857473

Importance of nucleation in transformation of octacalcium phosphate to hydroxyapatite.

Natsuko Ito1, Masanobu Kamitakahara2, Masahiro Yoshimura3, Koji Ioku4.   

Abstract

Octacalcium phosphate (OCP) is regarded as an in vivo precursor of hydroxyapatite (HA). It is important to understand the mechanism of transformation of OCP to HA in order to reveal the mechanism of mineralization and help in the development of artificial bone-repairing materials. Herein, we have examined the behavior of OCP in a simulated body fluid (SBF) and pure water. The OCP particles immersed in the SBF at 37 °C did not transform to HA even after 720 h of immersion, though the particles showed crystal growth. In distilled water at 60 °C, the OCP particles transformed to HA but the unreactive period was observed. Although the immersed solution became supersaturated with HA within 12h of immersion, the OCP was not transformed in the first 36 h of immersion. These results indicate that the nucleation of HA is the rate-determining step in the transformation of OCP to HA.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hydroxyapatite; Octacalcium phosphate; Transformation

Mesh:

Substances:

Year:  2014        PMID: 24857473     DOI: 10.1016/j.msec.2014.03.034

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  2 in total

1.  Fabrication of octacalcium phosphate block through a dissolution-precipitation reaction using a calcium sulphate hemihydrate block as a precursor.

Authors:  Yuki Sugiura; Melvin L Munar; Kunio Ishikawa
Journal:  J Mater Sci Mater Med       Date:  2018-09-27       Impact factor: 3.896

2.  Hydrothermally processed 1D hydroxyapatite: Mechanism of formation and biocompatibility studies.

Authors:  Zoran S Stojanović; Nenad Ignjatović; Victoria Wu; Vojka Žunič; Ljiljana Veselinović; Srečo Škapin; Miroslav Miljković; Vuk Uskoković; Dragan Uskoković
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2016-06-16       Impact factor: 7.328

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.